Melanoma in situ : Part I. Epidemiology, screening, and clinical features - 15/07/15
, Kachiu C. Lee, MD, MPH a, Anjela Galan, MD c, David J. Leffell, MD bAbstract |
The incidence of melanoma has steadily increased over the past 3 decades, with melanoma in situ comprising a disproportionately high percentage of the rising incidence. Our understanding of melanoma in situ has been shaped by epidemiologic and clinical studies. Central to a review of melanoma in situ is a focus on its epidemiology, pathology, biologic behavior, treatment, and clinical outcome, which may differ significantly from that of malignant melanoma. Part I of this continuing medical education article reviews the epidemiology, risk factors, and clinical features of melanoma in situ; part II covers the histopathology, treatment options, and clinical management.
Le texte complet de cet article est disponible en PDF.Key words : lentigo maligna, melanoma, melanoma in situ
Abbreviations used : MIS, MM, PPV, SCREEN, SEER, SPF
Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
|
| Date of release: August 2015 |
|
| Expiration date: August 2018 |
Vol 73 - N° 2
P. 181-190 - août 2015 Retour au numéro
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?